Chapman Financial Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$257K Sell
877
-40
-4% -$13.1K 0.18% 111
2025
Q4
$321K Sell
917
-260
-22% -$87.9K 0.22% 100
2025
Q3
$380K Sell
1,177
-904
-43% -$281K 0.26% 91
2025
Q2
$809K Buy
+2,081
New +$837K 0.69% 50
2024
Q4
$674K Buy
+1,827
New +$765K 0.54% 59

Other funds holding ELV

Chapman Financial Group's ELV Position: Q1 2026 in Review

Chapman Financial Group reduced its Elevance Health (ELV) stake by 4.4% in Q1 2026, selling an estimated $13.1K and leaving 877 shares worth $257K. The position accounts for 0.18% of the portfolio, ranked #111.

Chapman Financial Group first reported a position in ELV in Q4 2024 and has held it in 5 quarters since. The position peaked at $809K in Q2 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Chapman Financial Group held 877 shares of Elevance Health worth $257K as of Q1 2026.
  • Chapman Financial Group sold 40 Elevance Health shares in Q1 2026, an estimated $13.1K.
  • Elevance Health made up 0.18% of Chapman Financial Group's portfolio in Q1 2026, its #111 holding.
  • Chapman Financial Group first reported a position in Elevance Health in Q4 2024 and has held it in 5 quarters since.
  • Chapman Financial Group's Elevance Health position peaked at $809K in Q2 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Chapman Financial Group's 13F filing for Q1 2026, filed 12 May 2026.